Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)

Objective: To investigate the role of anti-cyclic citrullinated peptide antibody (anti-CCP) for the prediction of radiological outcome in patients with early rheumatoid arthritis. Methods: Anti-CCP was assessed at baseline in 379 patients with early rheumatoid arthritis (disease duration

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of the rheumatic diseases 2004-09, Vol.63 (9), p.1090-1095
Hauptverfasser:	Forslind, K, Ahlmén, M, Eberhardt, K, Hafström, I, Svensson, B
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult AFA Aged AKA antifilaggrin antibody antikeratin antibody antiperinuclear factor APF Arthritis, Rheumatoid - diagnostic imaging Arthritis, Rheumatoid - immunology Autoantibodies - blood BARFOT better anti-rheumatic farmacotherapy study Biological and medical sciences Biomarkers - blood CCP Clinical Medicine Confidence intervals cyclic citrullinated peptides DAS disease activity score disease modifying antirheumatic drug Disease Progression Diseases of the osteoarticular system DMARD Extended Report Female HAQ health assessment questionnaire HLA-DR Antigens - blood HLA-DRB1 Chains Humans ICC Immunoglobulins Inflammatory joint diseases intraclass correlation coefficient Klinisk medicin Larsen score Male Medical and Health Sciences Medical prognosis Medical sciences Medicin och hälsovetenskap Middle Aged Mortality negative predictive value NPV Peptides Peptides, Cyclic - immunology positive predictive value PPV Prognosis Radiography Reumatologi och inflammation Rheumatism Rheumatoid arthritis rheumatoid factor Rheumatoid Factor - blood Rheumatology and Autoimmunity Severity of Illness Index Statistics as Topic VAS visual analogue scale
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective: To investigate the role of anti-cyclic citrullinated peptide antibody (anti-CCP) for the prediction of radiological outcome in patients with early rheumatoid arthritis. Methods: Anti-CCP was assessed at baseline in 379 patients with early rheumatoid arthritis (disease duration
ISSN:	0003-4967 1468-2060 1468-2060
DOI:	10.1136/ard.2003.014233